Your browser doesn't support javascript.
loading
Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines.
Slagboom, Tessa N A; van Bunderen, Christa C; De Vries, Ralph; Bisschop, Peter H; Drent, Madeleine L.
Afiliação
  • Slagboom TNA; Department of Endocrinology and Metabolism, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands. t.slagboom@amsterdamumc.nl.
  • van Bunderen CC; Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands. t.slagboom@amsterdamumc.nl.
  • De Vries R; Department of Endocrinology and Metabolism, Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
  • Bisschop PH; Division of Endocrinology, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Drent ML; Medical Library, Vrije Universiteit, Amsterdam, The Netherlands.
Pituitary ; 26(4): 319-332, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37210433
OBJECTIVE: Diagnostic delay is high in acromegaly and leads to increased morbidity and mortality. The aim of this study is to systematically assess the most prevalent clinical signs, symptoms and comorbidities of acromegaly at time of diagnosis. DESIGN: A literature search (in PubMed, Embase and Web of Science) was performed on November 18, 2021, in collaboration with a medical information specialist. METHODS: Prevalence data on (presenting) clinical signs, symptoms and comorbidities at time of diagnosis were extracted and synthesized as weighted mean prevalence. The risk of bias was assessed for each included study using the Joanna Briggs Institute Critical Appraisal Checklist for Studies Reporting Prevalence Data. RESULTS: Risk of bias and heterogeneity was high in the 124 included articles. Clinical signs and symptoms with the highest weighted mean prevalence were: acral enlargement (90%), facial features (65%), oral changes (62%), headache (59%), fatigue/tiredness (53%; including daytime sleepiness: 48%), hyperhidrosis (47%), snoring (46%), skin changes (including oily skin: 37% and thicker skin: 35%), weight gain (36%) and arthralgia (34%). Concerning comorbidities, acromegaly patients more frequently had hypertension, left ventricle hypertrophy, dia/systolic dysfunction, cardiac arrhythmias, (pre)diabetes, dyslipidemia and intestinal polyps- and malignancy than age- and sex matched controls. Noteworthy, cardiovascular comorbidity was lower in more recent studies. Features that most often led to diagnosis of acromegaly were typical physical changes (acral enlargement, facial changes and prognatism), local tumor effects (headache and visual defect), diabetes, thyroid cancer and menstrual disorders. CONCLUSION: Acromegaly manifests itself with typical physical changes but also leads to a wide variety of common comorbidities, emphasizing that recognition of a combination of these features is key to establishing the diagnosis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Acromegalia / Diabetes Mellitus / Hipertensão Tipo de estudo: Diagnostic_studies / Guideline / Prevalence_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Pituitary Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Acromegalia / Diabetes Mellitus / Hipertensão Tipo de estudo: Diagnostic_studies / Guideline / Prevalence_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Pituitary Ano de publicação: 2023 Tipo de documento: Article